New U.S. patent issued covering the identification of a novel biomarker of coronavirus pneumonia (≤60% fraction of inspired oxygen (FiO2)) prognostic for potential opaganib efficacy in treating ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback